Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
Conditions
- Non-Small Cell Lung Cancer
Interventions
Sponsor
University Hospital, Montpellier